dms retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide shows significant weight loss

Optogenetic enhancement of inhibitory parvalbumin (PV)-expressing interneurons rapidly rescues social deficits and hyperactivity in adult ASD model mice lacking CNTNAP2 (31)

Unprecedented glutathione absorption allows for micro-dosing the intake of glutathione in lesser amounts than previously required to achieve therapeutic benefits and support health functions.* Tesseract Medical Research is committed to Good Manufacturing Practices (GMP)

A healthier glow and more hydrated look

Future Directions in Semaglutide Research for Fibroid Management Research on semaglutide for fibroid management is still evolving, and the future holds promising directions for better understanding and utilization of this treatment